LeonaBio (LONA) Total Liabilities (2019 - 2026)
LeonaBio (LONA) posted quarterly Total Liabilities of $22.3 million for Q1 2026, up 260.46% year-over-year from $6.2 million in Q1 2025, and down 65.37% quarter-over-quarter from $64.4 million in Q4 2025.
LeonaBio (LONA) Total Liabilities (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Total Liabilities for 8 consecutive years, with $22.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 260.46% year-over-year to $22.3 million; the TTM figure through Mar 2026 stood at $22.3 million (up 260.46% YoY), while the FY2025 annual figure was $64.4 million, up 361.77% from the prior year.
- Total Liabilities slipped to $22.3 million in Q1 2026 per LONA's latest filing, from $64.4 million in the prior quarter.
- Across five years, Total Liabilities topped out at $64.4 million in Q4 2025 and bottomed at $3.2 million in Q3 2025.
- Historically, Total Liabilities has averaged $21.1 million across 5 years, with a median of $22.3 million in 2026.
- On a YoY basis, Total Liabilities climbed as much as 361.77% in 2025 and fell as far as 88.67% in 2025.
- LeonaBio's Total Liabilities stood at $23.0 million in 2022, then surged by 30.59% to $30.1 million in 2023, then slumped by 53.63% to $13.9 million in 2024, then surged by 361.77% to $64.4 million in 2025, then plunged by 65.37% to $22.3 million in 2026.
- Business Quant data shows LONA's Total Liabilities at $22.3 million in Q1 2026, $64.4 million in Q4 2025, and $3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | 23.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.29 Mn |
| Dec 31, 2025 | 64.36 Mn |
| Sep 30, 2025 | 3.25 Mn |
| Jun 30, 2025 | 3.56 Mn |
| Mar 31, 2025 | 6.18 Mn |
| Dec 31, 2024 | 13.94 Mn |
| Sep 30, 2024 | 28.66 Mn |
| Jun 30, 2024 | 27.92 Mn |
| Mar 31, 2024 | 26.72 Mn |
| Dec 31, 2023 | 30.06 Mn |
| Sep 30, 2023 | 29.94 Mn |
| Jun 30, 2023 | 23.07 Mn |
| Mar 31, 2023 | 21.65 Mn |
| Dec 31, 2022 | 23.02 Mn |
| Sep 30, 2022 | 11.94 Mn |
| Jun 30, 2022 | 11.45 Mn |
| Mar 31, 2022 | 11.03 Mn |
| Dec 31, 2021 | 10.92 Mn |
| Sep 30, 2021 | 11.09 Mn |
| Jun 30, 2021 | 9.42 Mn |